# A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants

> **NCT07180862** · PHASE1 · RECRUITING · sponsor: **Bio-Thera Solutions** · enrollment: 140 (estimated)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** BAT3306
- **DRUG:** US-Keytruda®

## Key facts

- **NCT ID:** NCT07180862
- **Lead sponsor:** Bio-Thera Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-14
- **Primary completion:** 2027-02-28
- **Final completion:** 2027-11-30
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07180862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07180862, "A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07180862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*